Key Events This Week
18 May: Stock opens at Rs.280.75, declines sharply by 2.85%
19 May: Downgrade to Hold rating announced amid mixed technical and valuation signals
21 May: Technical momentum shifts from sideways to mildly bullish
22 May: Week closes at Rs.273.70, down 2.51% for the week

Artemis Medicare Services Ltd Shows Mildly Bullish Momentum Amid Mixed Technical Signals
2026-05-22 08:04:14Artemis Medicare Services Ltd, a small-cap player in the hospital sector, has experienced a subtle shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. Despite a modest day change of 0.05%, the stock’s technical indicators reveal a nuanced picture that investors should carefully analyse amid broader market volatility.
Read full news article
Artemis Medicare Services Ltd Downgraded to Hold Amid Mixed Technical and Valuation Signals
2026-05-19 08:57:39Artemis Medicare Services Ltd, a prominent player in the hospital sector, has seen its investment rating downgraded from Buy to Hold as of 18 May 2026. This revision reflects a nuanced reassessment across four key parameters: quality, valuation, financial trend, and technicals. While the company continues to demonstrate robust financial performance and operational strength, evolving market dynamics and technical indicators have prompted a more cautious stance among analysts.
Read full news article
Artemis Medicare Services Ltd Sees Technical Momentum Shift Amid Mixed Indicators
2026-05-19 08:06:56Artemis Medicare Services Ltd, a small-cap player in the hospital sector, has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend. Despite a recent downgrade in its Mojo Grade from Buy to Hold, the stock’s mixed technical indicators suggest a complex outlook for investors navigating the current market environment.
Read full news articleArtemis Medicare Services Ltd Gains 5.80%: 3 Key Factors Driving the Week’s Momentum
2026-05-16 12:00:59
Key Events This Week
11 May: Intraday high surge to Rs.289.25, outperforming Sensex by 8.89%
12 May: Quality grade upgraded from average to good, Mojo Score raised to 71.0
12 May: Rating upgraded from Hold to Buy on strong fundamentals and technicals
15 May: Week closes at Rs.280.75, up 5.80% vs Sensex down 2.63%

Artemis Medicare Services Ltd Upgraded to Buy on Strong Fundamentals and Technicals
2026-05-12 09:01:55Artemis Medicare Services Ltd has been upgraded from a Hold to a Buy rating, reflecting significant improvements across quality, valuation, financial trends, and technical indicators. This upgrade, effective from 11 May 2026, underscores the company’s robust operational performance, attractive valuation metrics, and positive market momentum within the hospital sector.
Read full news article
Artemis Medicare Services Ltd Upgrades Quality Grade Amid Strong Financial Metrics
2026-05-12 08:00:14Artemis Medicare Services Ltd has recently seen its quality grade upgraded from average to good, reflecting significant improvements in its business fundamentals. This upgrade, accompanied by a Mojo Score rise to 71.0 and a Buy rating, signals enhanced operational efficiency, stronger returns, and better financial health. Investors should consider how these changes position the company within the competitive hospital sector and what it means for future growth prospects.
Read full news article
Artemis Medicare Services Ltd Surges 7.48% to Day's High of Rs 289.25 — Outperforms Sector by 8.21 Percentage Points
2026-05-11 10:31:04While the Sensex declined by 1.41% on 11 Jun 2026, Artemis Medicare Services Ltd surged 7.48%, touching an intraday high of Rs 289.25. This 8.21-percentage-point outperformance over its Hospital sector peers signals a distinctly stock-specific rally rather than a market-wide lift.
Read full news articleAre Artemis Medicare Services Ltd latest results good or bad?
2026-05-09 19:18:02Artemis Medicare Services Ltd's latest financial results for Q4 FY26 reveal a complex picture of operational performance. The company reported a net profit of ₹30.03 crores, reflecting a substantial quarter-on-quarter growth of 34.42% and a year-on-year increase of 30.40%. Revenue for the quarter reached ₹279.23 crores, which is a modest sequential growth of 2.53% and a more significant year-on-year rise of 16.39%. Operating margins showed notable fluctuations throughout the fiscal year, with Q4 margins at 18.48%, marking the highest level in seven quarters. This margin expansion was attributed to improved operating leverage and effective cost management, particularly in employee costs, which constituted 16.10% of sales. However, the volatility in operating margins throughout FY26—from 16.24% in Q1 to 18.42% in Q2, then down to 16.36% in Q3—raises questions about the sustainability of these profitability ...
Read full news articleAnnouncement under Regulation 30 (LODR)-Newspaper Publication
15-May-2026 | Source : BSENewspaper Publication for opening of the special window for transfer and dematerialisation of physical securities
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
15-May-2026 | Source : BSETranscript of Earnings Conference Call - Q4 and FY26
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
11-May-2026 | Source : BSEAudio Recording of Earnings Conference Call - Q4 and FY26
Corporate Actions
No Upcoming Board Meetings
Artemis Medicare Services Ltd has declared 45% dividend, ex-date: 11 Jul 25
Artemis Medicare Services Ltd has announced 1:10 stock split, ex-date: 23 Sep 21
No Bonus history available
No Rights history available






